TL1A is a TNF-like ligand and functions as a T cell for DR3 and TR6/DcR3 costimulator

被引:524
作者
Migone, TS [1 ]
Zhang, J [1 ]
Luo, X [1 ]
Zhuang, L [1 ]
Chen, C [1 ]
Hu, BG [1 ]
Hong, JS [1 ]
Perry, JW [1 ]
Chen, SF [1 ]
Zhou, JXH [1 ]
Cho, YH [1 ]
Ullrich, S [1 ]
Kanakaraj, P [1 ]
Carrell, J [1 ]
Boyd, E [1 ]
Olsen, HS [1 ]
Hu, G [1 ]
Pukac, L [1 ]
Liu, D [1 ]
Ni, J [1 ]
Kim, S [1 ]
Gentz, R [1 ]
Feng, P [1 ]
Moore, PA [1 ]
Ruben, SM [1 ]
Wei, P [1 ]
机构
[1] Human Genome Sci Inc, Rockville, MD 20850 USA
关键词
D O I
10.1016/S1074-7613(02)00283-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DR3 is a death domain-containing receptor that is upregulated during T cell activation and whose overexpression induces apoptosis and NF-kappaB activation in cell lines. Here we show that an endothelial cell-derived TNF-like factor, TL1A, is a ligand for DR3 and decoy receptor TR6/DcR3 and that its expression is inducible by TNF and IL-1alpha. TL1A induces NF-kappaB activation and apoptosis in DR3-expressing cell lines, while TR6-Fc protein antagonizes these signaling events. Interestingly, in T cells, TL1A acts as a costimulator that increases IL-2 responsiveness and secretion of proinflammatory cytokines both in vitro and in vivo. Our data suggest that interaction of TL1A with DR3 promotes T cell expansion during an immune response, whereas TR6 has an opposing effect.
引用
收藏
页码:479 / 492
页数:14
相关论文
共 30 条
[1]   Apoptosis control by death and decoy receptors [J].
Ashkenazi, A ;
Dixit, VM .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :255-260
[2]   Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster [J].
Bai, C ;
Connolly, B ;
Metzker, ML ;
Hilliard, CA ;
Liu, XM ;
Sandig, V ;
Soderman, A ;
Galloway, SM ;
Liu, QY ;
Austin, CP ;
Caskey, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1230-1235
[3]   TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) [J].
Bodmer, JL ;
Burns, K ;
Schneider, P ;
Hofmann, K ;
Steiner, V ;
Thome, M ;
Bornand, T ;
Hahne, M ;
Schroter, M ;
Becker, K ;
Wilson, A ;
French, LE ;
Browning, JL ;
MacDonald, HR ;
Tschopp, J .
IMMUNITY, 1997, 6 (01) :79-88
[4]   Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 [J].
Chinnaiyan, AM ;
ORourke, K ;
Yu, GL ;
Lyons, RH ;
Garg, M ;
Duan, DR ;
Xing, L ;
Gentz, R ;
Ni, J ;
Dixit, VM .
SCIENCE, 1996, 274 (5289) :990-992
[5]  
Connolly K, 2001, J PHARMACOL EXP THER, V298, P25
[6]  
ECK MJ, 1992, J BIOL CHEM, V267, P2119
[7]   Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3) [J].
Kaptein, A ;
Jansen, M ;
Dilaver, G ;
Kitson, J ;
Dash, L ;
Wang, E ;
Owen, MJ ;
Bodmer, JL ;
Tschopp, J ;
Farrow, SN .
FEBS LETTERS, 2000, 485 (2-3) :135-141
[8]   A death-domain-containing receptor that mediates apoptosis [J].
Kitson, J ;
Raven, T ;
Jiang, YP ;
Goeddel, DV ;
Giles, KM ;
Pun, KT ;
Grinham, CJ ;
Brown, R ;
Farrow, SN .
NATURE, 1996, 384 (6607) :372-375
[9]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497
[10]   The TNF and TNF receptor superfamilies: Integrating mammalian biology [J].
Locksley, RM ;
Killeen, N ;
Lenardo, MJ .
CELL, 2001, 104 (04) :487-501